Skip to search formSkip to main contentSkip to account menu
Daunomycin-induced cardiotoxicity in children and adults. A review of 110 cases.
View on PubMed
5-Azacytidine. A new anticancer drug with effectiveness in acute myelogenous leukemia.
TLDR
Clinical results in solid tumors are not encouraging, but 5-azacytidine shows consistent antitumor activity in patients with acute myelogenous leukemia resistant to previous treatment.
View on PubMed
Cis-diamminedichloroplatinum (II). A new anticancer drug.
TLDR
Gastrointestinal, renal, audiologic, and relatively minor hematologic toxicities may be encountered, but promising methods have been developed to increase the therapeutic index of DDP.
View on PubMed
Quantitative prediction of drug toxicity in humans from toxicology in small and large animals.
TLDR
If the starting dose in Phase 1 clinical trials had been selected by calculating one-third of the toxic dose low (in mg/sq m) in the most sensitive large animal species, 5 of the 30 drugs would have produced significant toxicity in the first patient.
View on PubMed
Interactions of lectins with membrane glycoproteins. Effects of concanavalin A on 5'-nucleotidase.
View on PubMed
Pyridoxine therapy for palmar-plantar erythrodysesthesia associated with continuous 5-fluorouracil infusion
TLDR
Considering the high incidence of PPE and response in previously untreated colon cancer patients who receive protracted continuous 5-FU, prophylactic pyridoxine in conjunction with this treatment modality might be useful.
View on Springer
Phase I clinical trial of spirogermanium.
TLDR
The principal clinical toxic effects observed in this phase I trial were neurologic, manifested as lethargy, dizziness, and ataxia, while a grand mal seizure was produced after an accidental overdose.
View on PubMed
High sensitivity ELISA determination of taxol in various human biological fluids.
View on PubMed
Phase I trial and pharmacokinetic study of intravenous and oral alpha-difluoromethylornithine.
Eflornithine-HCl (alpha-difluoromethylornithine or DFMO), an irreversible inhibitor of ornithine decarboxylase, blocks polyamine synthesis and has demonstrated antitumor activity in cell culture and…
View on PubMed
Chemotherapy of cancer
TLDR
This guide covers every anticancer drug commonly used in Europe and the United States and includes new advances in combined modality therapy and immunotherapy, as well as new anticancer drugs now being tested in laboratories around the world.
View via Publisher
...
...
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License